Antisense Oligonucleotide Therapy for Calmodulinopathy.
antisense oligonucleotide
calmodulinopathy
precision medicine
Journal
Circulation
ISSN: 1524-4539
Titre abrégé: Circulation
Pays: United States
ID NLM: 0147763
Informations de publication
Date de publication:
19 Aug 2024
19 Aug 2024
Historique:
medline:
19
8
2024
pubmed:
19
8
2024
entrez:
19
8
2024
Statut:
aheadofprint
Résumé
Calmodulinopathies are rare inherited arrhythmia syndromes caused by dominant heterozygous variants in We tested this hypothesis using human induced pluripotent stem cell-derived cardiomyocyte and mouse models of Human These results provide proof of concept that ASOs targeting individual calmodulin genes are potentially effective and safe therapies for calmodulinopathies.
Sections du résumé
BACKGROUND
UNASSIGNED
Calmodulinopathies are rare inherited arrhythmia syndromes caused by dominant heterozygous variants in
METHODS
UNASSIGNED
We tested this hypothesis using human induced pluripotent stem cell-derived cardiomyocyte and mouse models of
RESULTS
UNASSIGNED
Human
CONCLUSIONS
UNASSIGNED
These results provide proof of concept that ASOs targeting individual calmodulin genes are potentially effective and safe therapies for calmodulinopathies.
Identifiants
pubmed: 39155863
doi: 10.1161/CIRCULATIONAHA.123.068111
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM